Shijiazhuang Yiling Pharmaceutical Co. Ltd

002603 · SZSE

Public Market Listing

002603SZSE

SZSE primary exchange listing

Live quotes, historical charts, and market capitalization for Shijiazhuang Yiling Pharmaceutical Co. Ltd are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Phase 3
FLT3Small molecule
Acute Myeloid Leukemia

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
July 2027 (1)
XY0206Phase 3Acute Myeloid Leukemia With FLT3/ITD Mutation
Est. primary completion 2027-07-01 · NCT05876832 · CT.gov ↗
What to watch

See the full readout calendar ↗

Financial reports

No financial reports recorded.